| Current Price | $9.77 | Mkt Cap | $167.54M |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 13.00 |
| Prev. Close | $9.91 | Div. (Yield) | N/A (N/A) |
| Daily Range | $9.74 - $10.06 | Volume | 20,424 |
| 52-Wk Range | $7.28 - $12.50 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Charter Medical Receives CE Mark Clearance for Next Generation Cell Freeze(R) Cryogenic Stem Cell Storage Containers 1/26/2012 4:16:45 PM -
- Market Report -- In Play (LDL) 1/26/2012 4:09:00 PM -
- Investigation of Lydall, Inc. by Securities Lawyers at Goldfarb Branham Law Firm LLP for Potential Shareholder Claims 1/25/2012 10:22:00 AM -
- Robbins Umeda LLP Announces an Investigation of Lydall, Inc. 1/10/2012 3:26:00 PM -
- Don't Get Too Worked Up Over Lydall's Earnings 4/22/2011 3:02:53 PM
- Lydall Passes This Key Test 4/14/2011 9:40:55 AM
- The Promise of Stem Cells: Which Insider Executives Are Buying Into Their Own Technology? 2/9/2011 1:41:15 PM
- Is 3M Working Hard Enough for You? 12/31/2010 6:23:14 PM
| Subject | Recs | Author | Date |
|---|
